Last viewed: NVS

Prices are updated after-hours

NVS Nyse 2020 - 02 - 12

Novartis AG

NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

(0.0% 1d) (-3.1% 1m) (-5.6% 1y) (0.0% 2d) (0.0% 3d) (-1.2% 7d) (Infinity% volume)
Earnings Calendar:
Market Cap: $ 206,641,841,697
http://www.novartis.com
Sec Filling | Patents | 103914 employees

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

add to watch list Paper trade email alert is off

Press-releases

Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published: 2024-04-17 (Crawled : 10:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M

|

Health Technology

| -4.36% | O: -0.26% H: 0.03% C: -1.55%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| 0.28% | O: 0.87% H: 0.16% C: -0.59%
RGNX | $15.67 -2.73% -2.87% 570K

|

Health Technology

| -4.57% | O: -1.43% H: 2.27% C: -3.18%
global dna market

Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published: 2024-04-17 (Crawled : 06:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| 0.28% | O: 0.87% H: 0.16% C: -0.59%
kesimpta sclerosis novartis show benefits

Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | $11.25 1.17% 1.16% 4.7M

|

Health Technology

| -1.77% | O: -0.53% H: 0.0% C: -1.24%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
PHG | $19.98 0.0% 540K

|

Health Technology

| -2.52% | O: -1.21% H: 0.0% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M

|

Health Technology

| -2.22% | O: -1.19% H: 0.52% C: -0.17%
VRNA | $15.82 -1.74% -1.83% 640K

|

Health Technology

| 1.9% | O: 1.65% H: 2.43% C: 0.87%
reach treatment research market

Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K

|

Health Technology

| -1.51% | O: -1.94% H: 0.43% C: -0.34%
OCUL | News | $5.22 -10.92% -12.26% 9.1M

|

Health Technology

| -3.1% | O: -1.03% H: 3.66% C: 1.7%
ocular key leaders

Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -0.29% | O: -1.75% H: 0.85% C: 0.85%
AZNCF | $138.24 -4.19% 800

|

Health Technology

| -0.47% | O: 2.1% H: 0.0% C: -2.52%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M

|

Health Technology

| -2.22% | O: -1.19% H: 0.52% C: -0.17%
BAX | $39.47 -0.45% 0.0% 2.8M

|

Health Technology

| -0.85% | O: -0.1% H: 0.13% C: -1.08%
ABBV | News | $166.41 1.06% 0.0% 5.5M

|

Health Technology

| 2.16% | O: 0.32% H: 0.96% C: 0.22%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -2.9% | O: -2.13% H: 0.0% C: 0.0%
BMRN S | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| -0.46% | O: -0.72% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| -0.68% | O: -0.64% H: 0.45% C: -0.04%
AMGN | $269.03 2.39% 2.33% 3.4M

|

Health Technology

| -0.22% | O: 0.41% H: 0.0% C: 0.0%
set therapeutics market

New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
fabhalta nephropathy for novartis show

Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -1.57% | O: 0.32% H: 0.04% C: -0.56%
ARVN | $34.78 1.43% 1.41% 940K

|

Health Technology

| -7.45% | O: 8.28% H: 0.56% C: -4.75%
arv-766 protac license cancer treatment global protein for commercialization agreement

Novartis tender offer for MorphoSys AG commences
Published: 2024-04-11 (Crawled : 09:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| -0.49% | O: -0.32% H: 0.48% C: -0.17%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -1.57% | O: 0.32% H: 0.04% C: -0.56%
MOR | $17.96 -0.5% -0.5% 180K

|

Health Technology

| 0.31% | O: 0.69% H: 0.0% C: -0.39%
for novartis

Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K

|

Health Technology

| -10.96% | O: -100.0% H: NaN% C: Infinity%
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| -2.16% | O: -1.67% H: 0.0% C: 0.0%
ALPMY | $9.47 -1.11% 520K

|

| -10.79% | O: -0.29% H: 0.0% C: -1.97%
VTRS | $11.25 1.17% 1.16% 4.7M

|

Health Technology

| -5.12% | O: -0.6% H: 1.03% C: 0.52%
TMO | News | $544.78 0.6% 0.0% 1.7M

|

Health Technology

| -9.54% | O: -2.01% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -2.71% | O: -1.16% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

| -7.38% | O: -1.71% H: 0.57% C: 0.37%
disorders system set market

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | $138.24 -4.19% 800

|

Health Technology

| 1.57% | O: -3.43% H: 6.21% C: 6.21%
VTRS | $11.25 1.17% 1.16% 4.7M

|

Health Technology

| -5.76% | O: -0.25% H: 1.1% C: -0.17%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -2.83% | O: -0.05% H: 0.43% C: -0.27%
BMY | $48.93 1.3% 0.0% 10M

|

Health Technology

| -5.88% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.69 1.05% 0.0% 2.9M

|

Health Technology

| -16.04% | O: 0.38% H: 0.0% C: -7.27%
ABBV | News | $166.41 1.06% 0.0% 5.5M

|

Health Technology

| -1.64% | O: 0.77% H: 1.63% C: 0.35%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -3.02% | O: 0.84% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| 1.21% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

See all

Last 15 days Sec forms

File Id

Form

Published Date

Transaction Date

Direction

Code

Amount Transacted

Owned Amount

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

|

EGOX | $0.0515 43.06% 30.1% 330M

|

OLB 4 | $0.33 -14.95% 25.53% 840K

|

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

|

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

|

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M

|

Distribution Services

INSG | $3.03 25.21% 20.13% 330K

|

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K

|

WLGS | News | $0.59 18.0% 17.9% 2.3M

|

ASNS | $0.828 21.75% 17.86% 18K

|

Last 48 Hours Insiders Buying

RXO P 1070000 | $19.37 2.32% 0.0% 1M

|

| 23:00
RKT | News P 380 | $11.68 1.3% 0.17% 1.9M

|

| 22:30
HROW | $10.43 -3.87% -4.03% 680K

|

Health Technology

| 22:30
BCDA | $0.377 -1.4% 97K

|

Health Technology

| 22:00
CLSD | $1.29 -2.27% -2.33% 230K

|

Health Technology

| 14:00
CDZI P 25000 | $2.25 0.0% 260K

|

| 14:00
ETST P 39000 | $0.068 -67.14% 43K

|

| 13:30
FNLC P 1275 | $22.97 3.66% 3.53% 21K

|

| 12:30
ADMQ | $0.0532 -40.18% 480K

|

| 10:30
AXR P 2400 | $21.0 -5.28% 0.0% 13K

|

| 21:00
QCRH P 118 | $57.315 3.44% 3.32% 66K

|

| 18:01
VUZI P 7500 | $1.19 -5.56% -5.88% 550K

|

Electronic Technology

| 18:00
RMCF | $3.67 3.38% 3.27% 11K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar